Revenue in the Online Pharmacy segment is projected to reach US$22.50bn in 2022.
Revenue is expected to show an annual growth rate (CAGR 2022-2026) of 11.45%, resulting in a projected market volume of US$34.71bn by 2026.
User penetration will be 21.54% in 2022 and is expected to hit 27.74% by 2026.
The average revenue per user (ARPU) is expected to amount to US$13.73.
In global comparison, most revenue will be generated in China (US$5,995.00m in 2022).
The Online Pharmacy includes over-the-counter medicine that can be purchased without a medical prescription through online sales channels. The segment comprises analgesics, cold and cough medication, digestives and intestinal remedies, skin treatment products, as well as vitamins and minerals. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
The data only reflects B2C revenues; B2B revenues are not covered.